Immune Regulation

BiotechnologySeries BCambridge, UKimmuneregulation.com

Latest round

Series B

Last raised

Sep 2020

Total raised

$58M

Investors

4

About Immune Regulation

Founded in 2011, Immune Regulation Limited operates from Cambridge, UK, primarily engaging in the digital domain market.Immune Regulation Limited offers its domain name, available for direct purchase or structured payment plans, catering to startups, healthcare organizations, and research institutions seeking to establish their online identity in the health and regulatory fields.60 mn to enhance its domain sales strategy and expand into new geographic markets. Specific initiatives include the development of new digital products aimed at improving customer engagement and satisfaction, with a focus on increasing market penetration in Europe and North America by 2025.

Who invested in Immune Regulation

4 investors across 2 rounds

See all investors in Immune Regulation

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Sep 21, 2020

    Amount

    $53M

    Investors

    Locked

  2. Series A

    Sep 28, 2017

    Amount

    $5.5M

    Investors

    Locked

Questions about Immune Regulation

Who invested in Immune Regulation?

Immune Regulation has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Immune Regulation raised?

Immune Regulation has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Immune Regulation last raise money?

Immune Regulation's most recent round on record is a Series B, in Sep 2020.

What does Immune Regulation do?

Founded in 2011, Immune Regulation Limited operates from Cambridge, UK, primarily engaging in the digital domain market.

Where is Immune Regulation headquartered?

Immune Regulation is headquartered in Cambridge, UK.

Which VCs invest in companies like Immune Regulation?

Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Immune Regulation's stage. Their profiles are linked below.

Raising like Immune Regulation? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.